Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Lowers Price Target to $60

Benzinga · 5d ago
Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and lowers the price target from $72 to $60.